These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 36405011)

  • 1. A Lamin Family-Based Signature Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma.
    Yang Y; Xiao W; Liu R; Gao L; Chen J; Kan H
    J Immunol Res; 2022; 2022():4983532. PubMed ID: 36405011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma.
    Zhu J; Huang Q; Peng X; Luo C; Liu Z; Liu D; Yuan H; Yuan R; Cheng X
    Front Immunol; 2023; 14():1218661. PubMed ID: 37662906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Predictive Model Based on the FBXO Family Reveals the Significance of Cyclin F in Hepatocellular Carcinoma.
    Gao D; Li S; Guo H; Liu X; Liu Z; Li L; Bao L; Dang X
    Front Biosci (Landmark Ed); 2024 May; 29(5):202. PubMed ID: 38812312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinoma.
    Yang Y; Gao L; Chen J; Xiao W; Liu R; Kan H
    Bioengineered; 2022 Apr; 13(4):9211-9231. PubMed ID: 35436411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Cholesterol Metabolism-Related lncRNA Signature Predicts the Prognosis of Patients with Hepatocellular Carcinoma and Their Response to Immunotherapy.
    Lei H; Xiang T; Zhu H; Hu X
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):129. PubMed ID: 38538256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel super-enhancer-related risk model for predicting prognosis and guiding personalized treatment in hepatocellular carcinoma.
    Wu Q; Li P; Tao X; Lin N; Mao B; Xie X
    BMC Cancer; 2024 Sep; 24(1):1087. PubMed ID: 39223584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel immunogenic cell death-related genes signature for predicting prognosis, immune landscape and immunotherapy effect in hepatocellular carcinoma.
    Xu G; Jiang Y; Li Y; Ge J; Xu X; Chen D; Wu J
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16261-16277. PubMed ID: 37698679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and validation of a novel signature based on epithelial-mesenchymal transition-related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment.
    Gao B; Wang Y; Lu S
    Funct Integr Genomics; 2022 Dec; 23(1):6. PubMed ID: 36536232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
    Li L; Xie R; Lu G
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel tumor immunotherapy-related signature for risk stratification, prognosis prediction, and immune status in hepatocellular carcinoma.
    Sun J; Xi L; Zhang D; Gao F; Wang L; Yang G
    Sci Rep; 2023 Oct; 13(1):18709. PubMed ID: 37907783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A T-cell-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma based on transcriptomics and single-cell sequencing.
    Chen X; Peng C; Chen Y; Ding B; Liu S; Song Y; Li Y; Sun B; Yang R
    BMC Bioinformatics; 2023 May; 24(1):216. PubMed ID: 37231356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma.
    Zhang X; Zhuge J; Liu J; Xia Z; Wang H; Gao Q; Jiang H; Qu Y; Fan L; Ma J; Tan C; Luo W; Luo Y
    Front Immunol; 2023; 14():1153423. PubMed ID: 37006285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cell Cycle Progression-Derived Gene Signature to Predict Prognosis and Therapeutic Response in Hepatocellular Carcinoma.
    Hui Y; Leng J; Jin D; Liu D; Wang G; Wang Q; Wang Y
    Dis Markers; 2021; 2021():1986159. PubMed ID: 34721731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
    Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic signature based on immunogenic cell death score predicts outcomes and response to transcatheter arterial chemoembolization and immunotherapy in hepatocellular carcinoma.
    Zhang Y; Yang J; Xie S; Chen H; Zhong J; Lin X; Yu Z; Xia J
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11411-11429. PubMed ID: 37382674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a four-gene metabolic signature predicting overall survival for hepatocellular carcinoma.
    Liu GM; Xie WX; Zhang CY; Xu JW
    J Cell Physiol; 2020 Feb; 235(2):1624-1636. PubMed ID: 31309563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
    Yang Z; Zi Q; Xu K; Wang C; Chi Q
    Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma.
    Zhang G; Zhang K; Zhao Y; Yang Q; Lv X
    BMC Cancer; 2022 Oct; 22(1):1103. PubMed ID: 36307751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma.
    Fang G; Zhang Q; Fan J; Li H; Ding Z; Fu J; Wu Y; Zeng Y; Liu J
    BMC Cancer; 2022 Sep; 22(1):999. PubMed ID: 36127654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.